# AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

> **NCT01300052** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 68 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** AN2728 ointment, 2%
- **DRUG:** Ointment Vehicle

## Key facts

- **NCT ID:** NCT01300052
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-26
- **Primary completion:** 2011-06-06
- **Final completion:** 2011-06-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300052, "AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01300052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*